Phlow Corp., a leading American advanced pharmaceutical contract development and manufacturing organization (CDMO), today announced that Dawn Von Rohr has been appointed Chief Operating Officer (COO).
Picarro Inc., a global leader in high-precision gas concentration analytical solutions, today announced the launch of the ...
A closer look at how robotics is reshaping pharmaceutical manufacturing, from improving quality and compliance to enabling more scalable production, and where the technology is headed next.
Pharmaceutical Contract Development And Manufacturing Organization Cdmo Market Pharmaceutical Contract Development · GlobeNewswire Inc. Dublin, Feb. 03, 2026 (GLOBE NEWSWIRE) -- The "Pharmaceutical ...
Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More Digital twins — a digital replica of the factory floor — are an important ...
FDA PERSPECTIVE: ADVANCED MANUFACTURING AND THE FUTURE OF PHARMACEUTICAL QUALITY In the opening remarks, Michael Kopcha, Director of the Office of Pharmaceutical Quality (OPQ), offered CDER’s ...
The global industrial sector is currently witnessing a critical shift toward ultra-fine material processing, a transformation driven by the increasing technical requirements of the pharmaceutical, new ...
Technological innovations throughout the past several decades have transformed the pharmaceutical manufacturing process from traditional batch production to ...
How CDMOs are reshaping pharmaceutical partnerships through friendshoring, risk-sharing economics, and specialized development capabilities. The pharmaceutical manufacturing landscape is undergoing a ...
Process development is the exercise of creating new and improved manufacturing methods, optimizing them in terms of time and financial efficiency while maintaining regulatory compliance and product ...
While braille is mandatory on all pharmaceutical packaging in Europe, U.S. regulatory agencies remain quiet on the issue, according to Pharmaceutical Processing. The U.S. Food and Drug Administration ...
In the opening remarks, Michael Kopcha, Director of the Office of Pharmaceutical Quality (OPQ), offered CDER’s perspective on advanced manufacturing and pharmaceutical quality. He began the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results